Jun Pang
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cancer, Lipids, and Metabolism 12
-
- Prostate Cancer Treatment and Research 27
- Prostate Cancer Diagnosis and Treatment 16
- Ferroptosis and cancer prognosis 7
Jun Pang
79 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 291
- Biomaterials 190
- Pulmonary and Respiratory Medicine 346
- Oncology 286
- Molecular Biology 566
Countries citing papers authored by Jun Pang
This map shows the geographic impact of Jun Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Pang more than expected).
Fields of papers citing papers by Jun Pang
This network shows the impact of papers produced by Jun Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Pang. The network helps show where Jun Pang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 25 | |
| 9 | 2022 | 22 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 28 | |
| 13 | 2020 | 36 | |
| 14 | 2020 | 66 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 12 | |
| 17 | 2018 | 47 | |
| 18 | 2013 | 7 | |
| 19 | Meta-Analysis of Ganglioside Treatment for Hypoxic-Ischemic Encephalopathy in Newborn Infants | 2012 | 1 |
| 20 | 2009 | 26 |
About Jun Pang
Jun Pang is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Biomaterials, Oncology and Rheumatology, having authored 91 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Nanoplatforms for cancer theranostics (13 papers), Cancer, Lipids, and Metabolism (12 papers), Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Ferroptosis and cancer prognosis (7 papers). The work is most often cited by research in Cancer Research (291 citations), Biomaterials (190 citations), Pulmonary and Respiratory Medicine (346 citations), Oncology (286 citations) and Molecular Biology (566 citations). Jun Pang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xin Gao, Yupeng Guan, Haiyun Xiong, Youqiang Fang, Tongyu Tong, Shiqiang Zhang, Li Ling, Yun Luo, Yang Kang and Binyuan Yan. Their work appears in journals such as Frontiers in Oncology, Advanced Healthcare Materials, BMC Cancer, Journal of Controlled Release and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.